These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15158540)

  • 41. Relevant anatomy for botulinum toxin facial rejuvenation.
    Loos BM; Maas CS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):439-43. PubMed ID: 15062247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facial aesthetics: achieving the natural, relaxed look.
    Carruthers A; Cohen JL; Cox SE; De Boulle K; Fagien S; Finn CJ; Flynn T; Lowe NJ; Raspaldo H; Sommer B; de Almeida AT
    J Cosmet Laser Ther; 2007; 9 Suppl 1():6-10. PubMed ID: 17885880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
    Lizarralde M; Gutiérrez SH; Venegas A
    Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the patient for cosmetic Botox injections.
    Dayan SH; Bassichis BA
    Facial Plast Surg Clin North Am; 2003 Aug; 11(3):349-58. PubMed ID: 15062263
    [No Abstract]   [Full Text] [Related]  

  • 49. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anatomic considerations for treatment with botulinum toxin.
    Petrus GM; Lewis D; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):1-9, v. PubMed ID: 17317550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.
    Rzany B; Dill-Müller D; Grablowitz D; Heckmann M; Caird D;
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S18-25. PubMed ID: 17241409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A; Carruthers J
    Semin Cutan Med Surg; 2001 Jun; 20(2):71-84. PubMed ID: 11474747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile).
    Polo M
    Am J Orthod Dentofacial Orthop; 2008 Feb; 133(2):195-203. PubMed ID: 18249285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cohort study on patient response to botulinum toxin cosmetic therapy.
    Lee H; Saladi RN; Fox JL
    J Cosmet Dermatol; 2008 Mar; 7(1):39-42. PubMed ID: 18254810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I; Modi P; Chajchir A
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botox in men.
    Flynn TC
    Dermatol Ther; 2007; 20(6):407-13. PubMed ID: 18093014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BOTOX use in the mid and lower face and neck.
    Carruthers J; Carruthers A
    Semin Cutan Med Surg; 2001 Jun; 20(2):85-92. PubMed ID: 11474748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altering brow contour with botulinum toxin.
    Chen AH; Frankel AS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):457-64. PubMed ID: 15062250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.